Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene

Archives of Toxicology

Volumn 86, Issue 2, 2012, Pages 195-203

  Selinski, Silvia ^a   Lehmann, Marie Louise ^a   Blaszkewicz, Meinolf ^a   Ovsiannikov, Daniel ^b   Moormann, Oliver ^b   Guballa, Christoph ^c   Kress, Alexander ^c   Tru, Michael C ^c   Gerullis, Holger ^d   Otto, Thomas ^d   Barski, Dimitri ^e   Niegisch, Günter ^e   Albers, Peter ^e   Frees, Sebastian ^f   Brenner, Walburgis ^f   Thüroff, Joachim W ^f   Angeli Greaves, Miriam ^g   Seidel, Thilo ^h   Roth, Gerhard ^h   Volkert, Frank ^h   Ebbinghaus, Rainer ⁱ   Prager, Hans Martin ⁱ   Lukas, Cordula ⁱ   Bolt, Hermann M ^a   Falkenstein, Michael ^a   Zimmermann, Anna ^a   Klein, Torsten ^j   Reckwitz, Thomas ^c   Roemer, Hermann C ^a,k   Hartel, Mark ^c   Weistenhöfer, Wobbeke ^a,l   Schöps, Wolfgang ^d   Rizvi, S Adibul Hassan ^m   Aslam, Muhammad ⁿ   Bánfi, Gergely ^o   Romics, Imre ^o   Ickstadt, Katja ^p   Hengstler, Jan G ^a   Golka, Klaus ^a   more..

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b St Josefs Hospital   (Germany)

^c KLINIKUM DORTMUND   (Germany)

^d Lukasklinik Neuss ^*  (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^h Paul Gerhardt Foundation   (Germany)

ⁱ Institute for Occupational   (Germany)

^j Gait Lab Social Pediatric Centre Children's Clinic St Vincenz Hospital   (Germany)

^k UNIVERSITY HOSPITAL ESSEN   (Germany)

^l UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^m SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

ⁿ UNIVERSITY OF KARACHI   (Pakistan)

^o SEMMELWEIS UNIVERSITY   (Hungary)

^p TU DORTMUND UNIVERSITY   (Germany)

more..

Author keywords

Ethnic differences; Genome wide association study (GWAS); Insulin growth factor 1 (IGF1); Single nucleotide polymorphism (SNP); Validation study

Indexed keywords

AROMATIC AMINE; AZO DYE; POLYCYCLIC AROMATIC HYDROCARBON; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGE; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GERMANY; HUMAN; HUNGARY; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 GENE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PAKISTAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; VENEZUELA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; HUNGARY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER NEOPLASMS; VENEZUELA;

EID: 84856971222     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-011-0747-5     Document Type: Article

References (43)

1. A Al-Zahrani MS Sandhu RN Luben, et al. 2006 IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer Hum Mol Genet 15 1 10 16306136 10.1093/hmg/ddi398 1:CAS:528:DC%2BD2MXhtlChsrrI (Pubitemid 43020099)
2. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
3. DA Bell JA Taylor DF Paulson CN Robertson JL Mohler GW Lucier 1993 Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer J Natl Cancer Inst 85 1159 1164 8320745 10.1093/jnci/85.14.1159 1:STN:280:DyaK3szgvVOmsw%3D%3D (Pubitemid 23212283)
4. F Canzian JD McKay RJ Cleveland, et al. 2006 Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study Br J Cancer 94 299 307 16404426 10.1038/sj.bjc.6602936 1:CAS:528:DC%2BD28XmvVyntg%3D%3D (Pubitemid 43151551)
5. I Cheng K DeLellis Henderson CA Haiman LN Kolonel BE Henderson ML Freedman L Le Marchand 2007 Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population J Clin Endocrinol Metab 92 3660 3666 17566087 10.1210/jc.2007-0790 1:CAS:528:DC%2BD2sXhtVGqsrfE (Pubitemid 47435353)
6. EF Costalonga SR Antonini G Guerra-Junior BB Mendonca IJ Arnhold AA Jorge 2009 The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency J Clin Endocrinol Metab 94 588 595 18984657 10.1210/jc.2008-1608 1:CAS:528:DC%2BD1MXhvFCqtrg%3D
7. A Cox AM Dunning M Garcia-Closas, et al. 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 352 358 17293864 10.1038/ng1981 1:CAS:528:DC%2BD2sXitVOktrY%3D (Pubitemid 46328496)
8. AA D'Aloisio JC Schroeder KE North, et al. 2009 IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women Cancer Epidemiol Biomarkers Prev 18 954 966 19240240 10.1158/1055-9965.EPI-08-0856
9. C Deal J Ma F Wilkin, et al. 2001 Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators J Clin Endocrinol Metab 86 1274 1280 11238520 10.1210/jc.86.3.1274 1:CAS:528:DC%2BD3MXitFWntLs%3D (Pubitemid 32323016)
10. SL Deming Z Ren W Wen XO Shu Q Cai YT Gao W Zheng 2007 Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study Breast Cancer Res Treat 104 309 319 17063263 10.1007/s10549-006-9420-8 1:CAS:528:DC%2BD2sXoslGhtLw%3D (Pubitemid 47231277)
11. WD Dupont WD Plummer 1990 Power and sample size calculations: a review and computer program Control Clin Trials 11 116 128 2161310 10.1016/0197- 2456(90)90005-M 1:STN:280:DyaK3c3mvFSjsw%3D%3D (Pubitemid 20136185)
12. WD Dupont WD Plummer 1998 Power and sample size calculations for studies involving linear regression Control Clin Trials 19 589 601 9875838 10.1016/S0197-2456(98)00037-3 1:STN:280:DyaK1M%2FptFSnsA%3D%3D (Pubitemid 29057724)
13. M García-Closas DW Hein D Silverman, et al. 2011 A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background Pharmacogenet Genomics 21 231 236 20739907
14. K Golka V Prior M Blaszkewicz, et al. 1996 Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany Scand J Work Environ Health 22 332 338 8923605 10.5271/sjweh.150 1:CAS:528:DyaK28XmvFWmsbY%3D (Pubitemid 26372136)
15. K Golka T Reckwitz M Kempkes, et al. 1997 N-Acetyltransferase 2 (NAT2) and glutathione S-transferase μ (GSTM1) in bladder-cancer patients in a highly industrialized area Int J Occup Environ Health 3 105 110 9891107 (Pubitemid 127816931)
16. K Golka M Hermes S Selinski, et al. 2009 Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure Pharmacogenet Genomics 19 903 906 19801959 10.1097/FPC.0b013e328331b554 1:CAS:528:DC%2BD1MXhsVSmsLnF
17. K Golka S Selinski ML Lehmann, et al. 2011 Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs" Arch Toxicol 85 539 554 21380501 10.1007/s00204-011-0676-3 1:CAS:528:DC%2BC3MXislyjtro%3D
18. JG Hengstler M Arand ME Herrero F Oesch 1998 Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility Recent Results Cancer Res 154 47 85 10026993 1:CAS:528:DyaK1cXmvFyrs70%3D
19. M Kempkes K Golka S Reich T Reckwitz HM Bolt 1996 Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder Arch Toxicol 71 123 126 9010594 10.1007/s002040050366 1:CAS:528:DyaK2sXns1KmtA%3D%3D (Pubitemid 26402878)
20. LA Kiemeney S Thorlacius P Sulem, et al. 2008 Sequence variant on 8q24 confers susceptibility to urinary bladder cancer Nat Genet 40 1307 1312 18794855 10.1038/ng.229 1:CAS:528:DC%2BD1cXhtlSkurnP
21. LA Kiemeney P Sulem S Besenbacher, et al. 2010 A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer Nat Genet 42 415 419 20348956 10.1038/ng.558 1:CAS:528:DC%2BC3cXjvFarsbo%3D
22. JH Lai D Vesprini W Zhang MJ Yaffe M Pollak SA Narod 2004 A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density Cancer Epidemiol Biomarkers Prev 13 573 582 15066922 1:CAS:528:DC%2BD2cXivVSisb0%3D (Pubitemid 38737893)
23. ML Lehmann S Selinski M Blaszkewicz, et al. 2010 Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk Arch Toxicol 84 967 978 21063684 10.1007/s00204-010-0617-6 1:CAS:528:DC%2BC3cXhtl2rtLbL
24. CM Lewis 2002 Genetic association studies: design, analysis and interpretation Briefings in Bioinformatics 3 146 153 12139434 10.1093/bib/3.2.146 1:CAS:528:DC%2BD38Xmt1Gmt7s%3D
25. JL Mong MC Ng GS Guldan, et al. 2009 Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents Int J Obes (Lond) 33 1446 1453 10.1038/ijo.2009.186 1:CAS:528:DC%2BD1MXhsFCqurzI
26. JW Moon YS Chang CW Ahn, et al. 2006 Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk Int J Cancer 118 353 356 16049980 10.1002/ijc.21339 1:CAS:528: DC%2BD2MXhtlWqsL7N (Pubitemid 41779074)
27. LE Moore DR Baris JD Figueroa, et al. 2011 GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis Carcinogenesis 32 182 189 21037224 10.1093/carcin/bgq223 1:CAS:528:DC%2BC3MXhsVSkt7w%3D
28. T Rafnar P Sulem SN Stacey, et al. 2009 Sequence variants at the TERT-CLPTM1L locus associate with many cancer types Nat Genet 41 221 227 19151717 10.1038/ng.296 1:CAS:528:DC%2BD1MXntFGlug%3D%3D
29. C Ricketts MP Zeegers J Lubinski ER Maher 2009 Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma PLoS One 4 e6037 19551141 10.1371/journal.pone.0006037
30. A Risch DM Wallace S Bathers E Sim 1995 Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer Hum Mol Genet 4 231 236 7757072 10.1093/hmg/4.2.231 1:CAS:528:DyaK2MXjvVagt7c%3D
31. AH Rosendahl M Hietala M Henningson H Olsson H Jernström 2011 IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families Breast Cancer Res Treat 127 785 794 21140206 10.1007/s10549-010-1277-1 1:CAS:528:DC%2BC3MXmtlyrsr0%3D
32. N Rothman M Garcia-Closas N Chatterjee, et al. 2010 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci Nat Genet 42 978 984 20972438 10.1038/ng.687 1:CAS:528:DC%2BC3cXhtlahu7fN
33. Safarinejad MR (2011) Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma. BJU Int 108:762-770
34. Safarinejad MR, Shafiei N, Safarinejad SH (2011) The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene. Arch Toxicol [Epub ahead of print]
35. S Saravana Devi N Vinayagamoorthy M Agrawal, et al. 2008 Distribution of detoxifying genes polymorphism in Maharastrian population of central India Chemosphere 70 1835 1839 17869325 10.1016/j.chemosphere.2007.08.008 (Pubitemid 351181329)
36. FR Schumacher I Cheng ML Freedman, et al. 2010 A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians Hum Mol Genet 19 3089 3101 20484221 10.1093/hmg/ddq210 1:CAS:528:DC%2BC3cXhtVahsLbL
37. Selinski S, Blaszkewicz M, Lehmann M-L et al (2011) Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype. Pharmacogenet Genomics [Epub ahead of print]
38. ML Slattery W Samowitz K Curtin KN Ma M Hoffman B Caan S Neuhausen 2004 Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer Cancer Epidemiol Biomarkers Prev 13 1206 1214 15247132 1:CAS:528:DC%2BD2cXlsFeksrY%3D (Pubitemid 38917910)
39. Terracciano D, Bruzzese D, Ferro M et al (2011) Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading. Prostate [Epub ahead of print]
40. KL Terry SS Tworoger MA Gates DW Cramer SE Hankinson 2009 Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk Carcinogenesis 30 2042 2046 19858071 10.1093/carcin/bgp257 1:CAS:528:DC%2BD1MXhsFGhurrM
41. K Wagner K Hemminki E Israelsson, et al. 2005 Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer Breast Cancer Res Treat 92 133 140 15986122 10.1007/s10549-005-2417-x 1:CAS:528:DC%2BD2MXls1ags7c%3D (Pubitemid 40933577)
42. L Wang T Habuchi N Tsuchiya, et al. 2003 Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer Cancer Res 63 4407 4411 12907612 1:CAS:528:DC%2BD3sXmtFeku7Y%3D (Pubitemid 36951011)
43. Wu X, Ye Y, Kiemeney LA, Sulem P et al (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 41:991-995; Erratum: Nat Genet 41:1156